PMID: 11902805Mar 21, 2002Paper

Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapy

The Journal of Pharmacy and Pharmacology
Sahar E el-SwefyHoda E Mohamed

Abstract

Hyperhomocysteinaemia is an independent risk factor for arteriosclerosis, recurrent thromboembolic complications and osteoporosis. After menopause, a high level of total homocysteine seems to be secondary to the altered hormonal status. Hormone replacement therapy (HRT) limits the development of coronary artery disease through a variety of mechanisms. One such mechanism is through affecting homocysteine metabolism. Folate and vitamin B12 deficiencies are considered to be major risks for hyperhomocysteinaemia. This study, therefore, was undertaken to examine whether lowering homocysteine with HRT or folic acid in ovariectomized rats could attenuate cardiovascular complications. Sixty sexually mature female Wistar rats were ovariectomized. Three weeks later, they were treated with estradiol (15 microg kg(-1), every two weeks, i.m.) or folic acid (90 microg daily, orally), either alone or in a combined form for four weeks. In addition, groups of ovariectomized rats (positive control) and healthy rats (negative control) were given cottonseed oil. Blood samples were then collected for serum and plasma separation. Serum total homocysteine, folate, estradiol, plasma nitric oxide (NO), lipid profile, and susceptibility of non-high-dens...Continue Reading

References

Apr 10, 1991·JAMA : the Journal of the American Medical Association·E Barrett-Connor, T L Bush
Mar 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·D G FrankenP W Kloppenborg
Jul 1, 1996·The Journal of Clinical Investigation·J Loscalzo
Oct 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·C ClementeA Di Leo
Mar 1, 1997·Metabolism: Clinical and Experimental·M H KimS S Kang
Feb 1, 1997·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A PinesP Kenemans
Jul 10, 1999·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·V MijatovicP Kenemans
Jan 15, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·H W WilminkT J Rabelink
Feb 17, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·J M FoodyD L Sprecher
Jun 13, 2000·Circulation Research·E S StroesT J Rabelink

❮ Previous
Next ❯

Citations

Jan 16, 2004·Pharmacology, Biochemistry, and Behavior·Beatrice SetnikJosé N Nobrega
Oct 22, 2003·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Reid HaywardKim C. Westerlind
Jul 11, 2009·Climacteric : the Journal of the International Menopause Society·S KilicS Batioglu
Mar 17, 2005·Life Sciences·Paulo José Forcina MartinsVânia D'Almeida
Sep 8, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Miguel Molina-HernándezM Teresa Jaramillo
Jan 26, 2006·Journal of Neuroscience Research·Andre Rex, H Fink
May 19, 2005·The Journal of Clinical Endocrinology and Metabolism·Paola VillaAntonio Lanzone

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.